InvestorsHub Logo
Followers 21
Posts 1095
Boards Moderated 0
Alias Born 01/28/2014

Re: Miladad post# 34442

Wednesday, 02/14/2024 5:49:46 PM

Wednesday, February 14, 2024 5:49:46 PM

Post# of 34588
Comparing #KALA, and it's IND approval
2nd $78 is all.time high.so if the tech is good, then lending 10-20 mil for trials will be the simple bet that anybbig pharma can afford, and they don't have shell $1.8 bil like Novo Nordisk


This could be a breakout year and a multi bagger stock this year

I never thought bumka would be diluting shit out of existing shareholders, and nicotine.deal will provide for biotech r&d


Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent LEXX News